A phase 1 pilot study to evaluate the safety and feasibility of ValloVax in all solid tumors.
Phase of Trial: Phase I
Latest Information Update: 15 Mar 2018
Price : $35 *
At a glance
- Drugs Placental-derived cell therapy-(ValloVax) (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 15 Mar 2018 According to a Batu Biologics media release, the company recently received FDA clearance to begin clinical trial.
- 28 Dec 2017 New trial record